Limited-Time October Offer: Try 7 Days for Free

Neurocrine Biosciences (0K6R.L) Stock Price

$136.6 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    7
  • Fundamental

    8
  • Technical

    5

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.

Sign up

0K6R.L AI Stock Analysis

Financial Performance

Neurocrine Biosciences has seen a decline in its financial performance. Revenue, gross profit, and operating income have all experienced significant decreases both quarterly and yearly. The EBITDA ratio of 0.04 also indicates a low level of operational profitability.

Stock Price

The stock price is currently at $136.63 with a downward trend over the past month (-2.7%). The RSI value of 40.18 suggests that the stock is nearing oversold territory, while the stock's 200-day moving average at $114.15 shows that it has been generally trending upwards in the longer term.

Alternative Data Signals

The company's website traffic has decreased by -11.9% month over month which may indicate lessening interest or engagement with their products or services. However, there has been an increase in job postings (up by 11.7% month over month), suggesting potential expansion or growth within the company despite current financial setbacks.

Around three-quarters of employees report having a positive business outlook but this figure represents a decrease from previous periods which could be cause for concern regarding employee sentiment and morale.

Social media followership on Twitter and Facebook have significantly increased in recent times which signals growing public awareness or interest in Neurocrine Biosciences.

Conclusion

In conclusion, whilst there are some positive signs such as increasing social media followership and job postings indicating potential future growth, current financial performance indicators are weak with declining revenue and profits making for a mixed bag overall hence giving us neutral AI stock analysis.

Neurocrine Biosciences (0K6R.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $136.6, will... Sign up to access price prediction.

About 0K6R.L

LSE
  • Neurocrine Biosciences, Inc.

  • Symbol

    0K6R.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    13.6B

News

No news articles.

0K6R.L Alternative Data

Web Traffic

Neurocrine Biosciences receives an estimated 33666 monthly visitors to neurocrine.com.

  • Web Traffic

    33666

  • Change from Previous Month

    11.9%

  • 3 Month Change

    28.6%

  • YoY Change

    28.6%

Twitter Followers

Neurocrine Biosciences has 821 Twitter Followers on its main Twitter (also known as X) account, which is up by 4.1% over the last month.

  • Twitter Followers

    821

  • Daily Change

    0.1%

  • 1 Month Change

    4.1%

  • 3 Month Change

    7.3%

  • YoY Change

    7.3%

Facebook Engagement

Neurocrine Biosciences has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    83.3%

  • 1 Month Change

    80%

  • 3 Month Change

    94.4%

  • YoY Change

    94.4%

Job Postings

Neurocrine Biosciences currenly has an estimated 86 open job postings, up by 19.4% over the last month.

  • Job Postings

    86

  • Daily Change

    0%

  • 1 Month Change

    19.4%

  • 3 Month Change

    11.7%

  • YoY Change

    11.7%

Reddit Mentions

Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

79,591 are following Neurocrine Biosciences on LinkedIn, up by 1.8% over the last month.

  • LinkedIn Followers

    79591

  • Daily Change

    1.8%

  • 1 Month Change

    1.8%

  • 3 Month Change

    6.6%

  • YoY Change

    6.6%

LinkedIn Employees

According to LinkedIn, Neurocrine Biosciences has 1,998 employees, up by 0.7% over the last month.

  • LinkedIn Employees

    1998

  • Daily Change

    0.7%

  • 1 Month Change

    0.7%

  • 3 Month Change

    3.5%

  • YoY Change

    3.5%

Business Outlook

According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 75 out of 100 (bullish).

  • Business Outlook

    75

  • Change from Previous Month

    8.5%

  • 3 Month Change

    9.6%

  • YoY Change

    9.6%

News Mentions

Neurocrine Biosciences was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0K6R.L Financials

0K6R.L Key Metrics
  • Total Revenue

    $572.6M

  • Net Income

    $7.9M

  • Earnings per Share

    $0.08

  • Free cash flow

    $54.1M

  • EBITDA

    $23.6M

  • EBITDA Ratio

    0.0412155

  • Total Assets

    $3.7B

0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow

0K6R.L Technicals

0K6R.L SMA
0K6R.L RSI

FAQ

What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $136.6.

What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 13.6B.

What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Esperion Therapeutics and Thermo Fisher Scientific Inc..

What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $144.4 in 2026. Starting from the current price of $136.6, this represents a 5.7% change in price, indicating a bullish outlook for the stock.

How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.